Elmind Capital »

Insmed shares owned by Elmind Capital

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.9M 65k 106.62

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Relay Therapeutics (RLAY)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
Pharvaris N V (PHVS)
Miragen Therapeutics (VRDN)
Cytomx Therapeutics (CTMX)
Travere Therapeutics (TVTX)
Legend Biotech Corp Sponsored Ads (LEGN)
Beam Therapeutics (BEAM)
Cullinan Oncology (CGEM)
Nurix Therapeutics (NRIX)
Krystal Biotech (KRYS)

View all positions for Elmind Capital

Top funds holding Insmed

FMR
BlackRock
Jpmorgan Chase & Co
Vanguard Portfolio Management
Vanguard Capital Management
Baker Bros. Advisors
Capital Research and Management Company - Division 3
Darwin Global Management
Ameriprise Financial
Orbis Allan Gray
D. E. Shaw & Co
State Street Corporation
Artisan Partners Limited Partnership
Rtw Investments
Geode Capital Management

View all funds holding Insmed